Compare WBI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WBI | ABCL |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | Canada |
| Employees | 540 | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | N/A | 2020 |
| Metric | WBI | ABCL |
|---|---|---|
| Price | $25.29 | $4.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $28.25 | $8.40 |
| AVG Volume (30 Days) | 884.6K | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,128,000.00 |
| Revenue This Year | $70.12 | N/A |
| Revenue Next Year | $17.89 | $21.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $18.64 | $1.94 |
| 52 Week High | $28.97 | $6.52 |
| Indicator | WBI | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 46.72 | 69.33 |
| Support Level | $24.78 | $3.91 |
| Resistance Level | $26.85 | $4.93 |
| Average True Range (ATR) | 1.17 | 0.16 |
| MACD | -0.11 | 0.06 |
| Stochastic Oscillator | 13.46 | 94.58 |
WaterBridge Infrastructure LLC is an integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates in the produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling, and handling produced water. It also operates two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment, and handling of produced water are crucial to oil and natural gas production.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.